A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Summary

The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris

Timeline

Start

2016-12-27

Primary completion

2017-11-28

Completion

2017-11-28

Outcome

Missed primary endpoint

registry analysis (other test); Olumacostat Glasaretil Gel, 5.0% vs Olumacostat Glasaretil Gel, Vehicle; p = 0.3430; ANCOVA NCT03028363 ↗

registry analysis (other test); Olumacostat Glasaretil Gel, 5.0% vs Olumacostat Glasaretil Gel, Vehicle; p = 0.1260; ANCOVA NCT03028363 ↗

registry analysis (other test); Olumacostat Glasaretil Gel, 5.0% vs Olumacostat Glasaretil Gel, Vehicle; p = 0.5247; Regression, Logistic NCT03028363 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Olumacostat Glasaretil	Small molecule	5 %	Topical

Indications